NCT05499611View on ClinicalTrials.gov

Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Myeloblastic Leukemia
Trial Locations (1)

Unknown

CHU de Bordeaux, service Hématologie Biologique, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER